Tuesday , October 17 2017
Home / Resources / Exclusive Interviews / The Risks Vs. Benefits When Setting A1C Targets

The Risks Vs. Benefits When Setting A1C Targets

In the conclusion of this Exclusive Interview, Dr. Rhinehart explains the necessity of taking the care of individuals into consideration when setting general health guidelines for the management of diabetes.

Andy Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC, is the Chief Medical Officer at Glytec Systems, a clinical information technology company dedicated to the mission of improving insulin management and glycemic control. Dr. Rhinehart previously served as a diabetologist and the program director of the Johnston Memorial Diabetes Care Center and Johnston Memorial Center for Comprehensive Wound Care in Abingdon, Va. He was also the chairman of the ADA’s Primary Care Advisory Group and the first physician to be Board Certified in Advanced Diabetes Management (BC-ADM) by the American Association of Diabetes Educators.